S Disthabanchong, P Srisuwarn - Advances in chronic kidney disease, 2019 - Elsevier
The increase in prevalence and severity of vascular calcification in chronic kidney disease is a result of complex interactions between changes in the vascular bed, mineral metabolites …
Background Chronic kidney disease (CKD) is an important cause of morbidity and mortality worldwide. There is a lack of information on epidemiology and progression of CKD in low …
L Anguiano, M Riera, J Pascual… - Nephrology Dialysis …, 2015 - academic.oup.com
Background Patients with cardiovascular (CV) disease have an increased circulating angiotensin-converting enzyme 2 (ACE2) activity, but there is little information about …
A Achim, OÁ Péter, M Cocoi, A Serban, S Mot… - Journal of …, 2023 - mdpi.com
Atherosclerosis is a multifactorial systemic disease that affects the entire arterial tree, although some areas are more prone to lipid deposits than others. Moreover, the …
M Gracia, A Betriu, M Martinez-Alonso… - Clinical Journal of the …, 2016 - journals.lww.com
Results Prevalence of atheromatosis was 68.7% and progressed in 59.8% of patients after 24 months. CKD progression was associated with atheromatosis progression, suggesting a …
Background: Chronic kidney disease (CKD) is an independent risk factor for atherosclerotic disease. We hypothesized that CKD promotes a proatherogenic lipid profile modifying …
Background Atherosclerosis is highly prevalent in people with chronic kidney disease (CKD), including those receiving peritoneal dialysis (PD). Although it is lifesaving, PD …
Introduction: Chronic kidney disease (CKD) is a world-wide health concern associated with a significantly higher cardiovascular morbidity and mortality. One of the principal …
N Dolade, S Rayego-Mateos… - Clinical …, 2023 - portlandpress.com
Background: In chronic kidney disease (CKD), cardiovascular morbi-mortality is higher than in general population. Atherosclerotic cardiovascular disease is accelerated in CKD, but …